[en] BACKGROUND: Whether healthcare workers with inflammatory bowel disease (IBD) are at increased risk of Novel coronavirus disease (COVID-19) due to occupational exposure is unknown. AIM: To assess the risk of COVID-19 in healthcare workers with IBD. METHODS: A case control study enrolled 326 healthcare workers with IBD from 17 GETAID centres and matched non-healthcare workers with IBD controls (1:1) for gender, age, disease subtype and year of diagnosis. The study period was year 2020 during the COVID-19 outbreak. RESULTS: In total, 59 COVID-19 were recorded among cases (n = 32) and controls (n = 27), including 2 severe COVID-19 (requiring hospitalization, mechanic ventilation) but no death. No difference was observed between healthcare workers and controls regarding the overall incidence rates of COVID-19 4.9 ± 2.2 vs. 3.8 ± 1.9 per 100 patient-semesters, P = 0.34) and the overall incidence rates of severe COVID-19 (0.6 ± 7.8 vs. 0.3 ± 5.5 per 100 patient-semesters, P = 0.42). In multivariate analysis in the entire study population, COVID-19 was associated with patients with body mass index > 30 kg/m(2) (HR = 2.48, 95%CI [1.13-5.44], P = 0.02). CONCLUSION: Healthcare workers with IBD do not have an increased risk of COVID-19 compared with other patients with IBD.
Disciplines :
Gastroenterology & hepatology
Author, co-author :
Amiot, Aurelien; Department of Gastroenterology, Bicêtre Hospital, AP-HP, Paris Est Creteil University, Le Kremlin Bicêtre, France.
Bourrier, Anne; Saint Antoine Hospital, Gastroenterology Unit, Centre de Recherche Saint-Antoine, Sorbonne Université, INSERM 75012, Assistance Publique-Hôpitaux de Paris, France.
Gornet, Jean-Marc; Department of Gastroenterology, Saint Louis University Hospital, AP-HP, Paris, France.
Dewit, Olivier; Department of HepatoGastroenterology, Catholic University of Leuven, University Hospital of Saint-Luc, Brussels, Belgium.
Nancey, Stephane; Department of Gastroenterology, Hospices Civils de Lyon and Claude Bernard Lyon 1 University, Pierre-Benite, France.
Altwegg, Romain; Department of Hepatogastroenterology, Saint-Eloi Hospital, Montpellier, France.
Abitbol, Vered; Department of Gastroenterology, Cochin University Hospital, University Paris 5 Descartes, Paris, France.
Laharie, David; Department of Hepato-Gastroenterology, University Hospital of Bordeaux, Hôpital Haut-Lévêque, Bordeaux, France.
Reenaers, Catherine ; Centre Hospitalier Universitaire de Liège - CHU > > Service de gastroentérologie, hépatologie, onco. digestive
Gagnière, Charlotte; Department of Gastroenterology, Hôpitaux Universitaires Henri Mondor, AP-HP, Créteil, France.
Buisson, Anthony; Department of Hepato-Gastroenterology, University Hospital Estaing of Clermont-Ferrand, Université d'Auvergne, Clermont-Ferrand, France.
Nachury, Maria; Department of Gastroenterology, Huriez University Hospital, Université Lille Nord de France, Lille, France.
Viennot, Stephanie; Department of Gastroenterology, Besançon University Hospital, Besançon, France.
Vuitton, Lucine; Department of Gastroenterology, Caen University Hospital, F-14000, Caen, France.
Stefanescu, Carmen; Department of Gastroenterology, IBD and Nutrition Support, Beaujon Hospital, University Paris 7 Denis Diderot, Clichy, France.
Marteau, Philippe; Sorbonne Université-APHP, Tenon Hospital, Paris, France.
Bouguen, Guillaume; Department of Gastroenterology, Pontchaillou Hospital and Rennes University, Rennes, France.
Seksik, Philippe; Saint Antoine Hospital, Gastroenterology Unit, Centre de Recherche Saint-Antoine, Sorbonne Université, INSERM 75012, Assistance Publique-Hôpitaux de Paris, France.
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579 (2020), 270–273, 10.1038/s41586-020-2012-7.
WHO Coronavirus Disease (COVID-19) Dashboard n.d. https://covid19.who.int (accessed January 9, 2021).
COVID-19 and outcomes in patients with inflammatory bowel disease: systematic review and meta-analysis - PubMed n.d. https://pubmed.ncbi.nlm.nih.gov/34718595/(accessed November 1, 2021).
Rubin, D.T., Abreu, M.T., Rai, V., Siegel, C.A., Management of Patients with Crohn's Disease and Ulcerative Colitis During the COVID-19 Pandemic: Results of an International Meeting. Gastroenterology, 2020, 10.1053/j.gastro.2020.04.002.
Gómez-Ochoa, S.A., Franco, O.H., Rojas, L.Z., Raguindin, P.F., Roa-Díaz, Z.M., Wyssmann, B.M., et al. COVID-19 in Health-Care Workers: A Living Systematic Review and Meta-Analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes. Am J Epidemiol 190 (2021), 161–175, 10.1093/aje/kwaa191.
Gagnière, C., Bourrier, A., Seksik, P., Gornet, J.-M., DeWit, O., Nancey, S., et al. Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID). Aliment Pharmacol Ther 48 (2018), 713–722, 10.1111/apt.14926.
Beaugerie L, Seksik P, Nion-Larmurier I, Gendre, Jean-Pierre, Cosnes J. Predictors of Crohn's disease. Gastroenterology n.d.;130:650–656.
Sokol, H., Seksik, P., Carrat, F., Nion-Larmurier, I., Vienne, A., Beaugerie, L., et al. Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy. Gut 59 (2010), 1363–1368, 10.1136/gut.2010.212712.
Rahier, J.F., Magro, F., Abreu, C., Armuzzi, A., Ben-Horin, S., Chowers, Y., et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 8 (2014), 443–468, 10.1016/j.crohns.2013.12.013.
Raina MacIntyre, C., Chughtai, A.A., Zhang, Y., Seale, H., Yang, P., Chen, J., et al. Viral and bacterial upper respiratory tract infection in hospital health care workers over time and association with symptoms. BMC Infect Dis, 17, 2017, 553, 10.1186/s12879-017-2649-5.
Xiao, J., Fang, M., Chen, Q., He, B., SARS, MERS and COVID-19 among healthcare workers: A narrative review. J Infect Public Health 13 (2020), 843–848, 10.1016/j.jiph.2020.05.019.
Publications & Data | European Centre for Disease Prevention and Control n.d. https://www.ecdc.europa.eu/en/publications-data (accessed April 8, 2021).
Bistoquet, M., Galtier, F., Marin, G., Villard, O., Ferreira, R., Hermabessiere, S., et al. Increased risks of SARS-CoV-2 nosocomial acquisition in high-risk COVID-19 units justify personal protective equipment: a cross-sectional study. J Hosp Infect 107 (2021), 108–110, 10.1016/j.jhin.2020.10.022.
Tripathi, K., Godoy Brewer, G., Thu Nguyen, M., Singh, Y., Saleh Ismail, M., Sauk, J.S., et al. COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. Inflamm Bowel Dis, 2021, 10.1093/ibd/izab236 izab236.
Guimarães, P.O., Quirk, D., Furtado, R.H., Maia, L.N., Saraiva, J.F., Antunes, M.O., et al. Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia. N Engl J Med 385 (2021), 406–415, 10.1056/NEJMoa2101643.
Alunno, A., Najm, A., Mariette, X., De Marco, G., Emmel, J., Mason, L., et al. Immunomodulatory therapies for the treatment of SARS-CoV-2 infection: an update of the systematic literature review to inform EULAR points to consider. RMD Open, 7, 2021, e001899, 10.1136/rmdopen-2021-001899.
Ko, J.Y., Danielson, M.L., Town, M., Derado, G., Greenlund, K.J., Kirley, P.D., et al. Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization: COVID-19-Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System. Clin Infect Dis Off Publ Infect Dis Soc Am 72 (2021), 695–703, 10.1093/cid/ciaa1419.
Bonnet, G., Weizman, O., Trimaille, A., Pommier, T., Cellier, J., Geneste, L., et al. Characteristics and outcomes of patients hospitalized for COVID-19 in France: The Critical COVID-19 France (CCF) study. Arch Cardiovasc Dis 114 (2021), 352–363, 10.1016/j.acvd.2021.01.003.
Czernichow, S., Beeker, N., Rives-Lange, C., Guerot, E., Diehl, J.-L., Katsahian, S., et al. Obesity Doubles Mortality in Patients Hospitalized for Severe Acute Respiratory Syndrome Coronavirus 2 in Paris Hospitals, France: A Cohort Study on 5,795 Patients. Obes Silver Spring Md 28 (2020), 2282–2289, 10.1002/oby.23014.
Petrakis, D., Margină, D., Tsarouhas, K., Tekos, F., Stan, M., Nikitovic, D., et al. Obesity - a risk factor for increased COVID-19 prevalence, severity and lethality (Review). Mol Med Rep 22 (2020), 9–19, 10.3892/mmr.2020.11127.
Hoong, C.W.S., Hussain, I., Aravamudan, V.M., Phyu, E.E., Lin, J.H.X., Koh, H., Obesity is Associated with Poor Covid-19 Outcomes: A Systematic Review and Meta-Analysis. Horm Metab Res Horm Stoffwechselforschung Horm Metab 53 (2021), 85–93, 10.1055/a-1326-2125.
Stabroth-Akil, D., Leifeld, L., Pfützer, R., Morgenstern, J., Kruis, W., The effect of body weight on the severity and clinical course of ulcerative colitis. Int J Colorectal Dis 30 (2015), 237–242, 10.1007/s00384-014-2051-3.
Flores, A., Burstein, E., Cipher, D.J., Feagins, L.A., Obesity in Inflammatory Bowel Disease: A Marker of Less Severe Disease. Dig Dis Sci 60 (2015), 2436–2445, 10.1007/s10620-015-3629-5.
Moser, J.-A.S., Galindo-Fraga, A., Ortiz-Hernández, A.A., Gu, W., Hunsberger, S., Galán-Herrera, J.-F., et al. Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses. Influenza Other Respir Viruses 13 (2019), 3–9, 10.1111/irv.12618.
